We have located links that may give you full text access.
Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis.
American Journal of Gastroenterology 2022 December 9
BACKGROUND: Treatment of primary biliary cholangitis (PBC) can improve the GLOBE score. We aimed to assess the association between changes in the GLOBE score (ΔGLOBE) and liver transplantation (LT)-free survival in patients with PBC who were treated with ursodeoxycholic acid (UDCA).
METHODS: Among UDCA-treated patients within the Global PBC cohort, the association between ΔGLOBE ( 0-1 : during first year of UDCA, 1-2 : during second year) and the risk of LT or death was assessed through Cox regression analyses.
RESULTS: Overall, 3775 UDCA-treated patients were included; 3424 [90.7%] were female, median age 54.0 (IQR 45.9-62.4) years and median baseline GLOBE score was 0.25 (IQR -0.47 - 0.96). During a median follow-up of 7.2 (IQR 3.7-11.5) years, 730 patients reached the combined endpoint of LT or death. Median ΔGLOBE 0-1 was -0.27 (IQR -0.56 - 0.02). Cox regression analyses, adjusted for pretreatment GLOBE score and ΔGLOBE 0-12 , showed that ΔGLOBE was associated with LT or death (adjusted HR 2.28, 95%CI 1.81-2.87, p <0.001). The interaction between baseline GLOBE score and ΔGLOBE 0-1 was not statistically significant ( p =0.296). The ΔGLOBE 1-2 was associated with LT or death (adjusted HR 2.19, 95%CI 1.67-2.86, p<0.001), independently from the baseline GLOBE score and de change in GLOBE score during the first year of UDCA.
CONCLUSION: UDCA-induced changes in the GLOBE score were significantly associated with LT-free survival in patients with PBC. While the relative risk reduction of LT or death was stable, the absolute risk reduction was heavily dependent on the baseline prognosis of the patient.
METHODS: Among UDCA-treated patients within the Global PBC cohort, the association between ΔGLOBE ( 0-1 : during first year of UDCA, 1-2 : during second year) and the risk of LT or death was assessed through Cox regression analyses.
RESULTS: Overall, 3775 UDCA-treated patients were included; 3424 [90.7%] were female, median age 54.0 (IQR 45.9-62.4) years and median baseline GLOBE score was 0.25 (IQR -0.47 - 0.96). During a median follow-up of 7.2 (IQR 3.7-11.5) years, 730 patients reached the combined endpoint of LT or death. Median ΔGLOBE 0-1 was -0.27 (IQR -0.56 - 0.02). Cox regression analyses, adjusted for pretreatment GLOBE score and ΔGLOBE 0-12 , showed that ΔGLOBE was associated with LT or death (adjusted HR 2.28, 95%CI 1.81-2.87, p <0.001). The interaction between baseline GLOBE score and ΔGLOBE 0-1 was not statistically significant ( p =0.296). The ΔGLOBE 1-2 was associated with LT or death (adjusted HR 2.19, 95%CI 1.67-2.86, p<0.001), independently from the baseline GLOBE score and de change in GLOBE score during the first year of UDCA.
CONCLUSION: UDCA-induced changes in the GLOBE score were significantly associated with LT-free survival in patients with PBC. While the relative risk reduction of LT or death was stable, the absolute risk reduction was heavily dependent on the baseline prognosis of the patient.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app